Valuation Resources

Biotechnology Companies

SIC 2836 | NAICS 325414

The following guide to industry information, research, and analysis provides sources for industry trends and statistics, financial ratios, salary surveys, and more.

Select from the following sections or scroll below to view available resources:
  • Industry Analysis, Trends, Statistics, and Forecasts
  • Financial Statements and Financial Ratios
  • Compensation and Salary Surveys
  • Business Valuation Resources

For guides to other industries, see our index of over 400 industries.

Share our guides with your colleagues and friends.

Industry Analysis, Trends, Statistics, and Forecasts

Human Health Biotechnology  (view report)
Animal Health Biotechnology  (view report)

Comprehensive research reports provide in-depth industry analysis and five-year growth forecasts, with special focus on the underlying structure and external forces and relationships that affect industries and their performance. Topics addressed in the reports include:

  • Market size, product segments, and major markets
  • Key statistics, market trends, and external drivers
  • Operating conditions and current performance
  • Competitive landscape and environment
  • Major company profiles and market shares
  • Five-year outlook and revenue forecast

Thomson Reuters
BioWorld Today / BioWorld Insights  Select "Explore - Publications" from top menu

Daily online news source and weekly report on market data and business trends provide in-depth coverage of the biopharmaceutical industry, with topics covered by these news sources including new product development, clinical trials, FDA approvals, regulatory updates, market performance, corporate financings, strategic alliances, mergers and acquisitions, and corporate restructurings.

Biotechnology Innovation Organization
TEConomy Report  Select report title from "Industry Insight & News" drop-down menu

Biennial report examines the economic value of bioscience innovation on an national and state basis, with topics covered on a state-by-state basis including establishment, employment, and wage trends, research and development expenditures, NIH funding levels, venture capital investments, and patent awards by bioscience-related class group. Full study and individual state profiles are available online.

Ernst & Young
Beyond Borders: Biotechnology Report

Annual E&Y publication analyzes key trends and their implications for the biotechnology sector in the U.S. and Europe, with content sections including the year in review, perspectives on selected topics from industry experts, key financial performance measures, capital financing activities, mergers and acquisitions, and strategic alliances. Current and prior reports can be downloaded and viewed online.

State of the Industry Report

Comprehensive report provides in-depth analysis of the biotechnology sector, with topics covered in the report including major trends and developments, public offerings and other financing and capital sources, mergers and acquisitions, underwriter and stock performance, restructuring transactions, and pending litigation. Detailed table of contents and excerpts from the report can be viewed online.

S&P Global Market Intelligence

Standard & Poor's survey provides in-depth coverage of the biotech industry, with topics covered in the report including industry performance and trends, operational overview, and key industry ratios and statistics, and with companies covered in the comparative company analysis section including Abbvie Inc., Amgen, Inc., Biogen, Inc., Gilead Sciences, Inc., and Regeneron Pharmaceuticals, Inc.

GIA Research

Comprehensive market research report provides in-depth analysis of the biopharmaceutical market in the U.S. and other countries, with data provided including historical and forecast sales by product segment (e.g., recombinant proteins, monoclonal antibodies, insulin, and vaccines) and companies profiled including AbbVie Inc., Eli Lilly and Company, Genentech, Inc., Pfizer, Inc., and Novartis AG.

More Resources »
Financial Statements and Financial Ratios

Industry Financial Ratios
Biotechnology Companies  Search for "3254"  to see reports for specific types of products

Five-year financial statement analysis includes income statements, balance sheets, and key financial ratios, with data available by sales size range on a national, state, and metro area level including:

  • Income and expenses in dollars and percentages
  • Balance sheets in dollars and percentages
  • Profitability and return on investment ratios
  • Liquidity and working capital ratios
  • Asset turnover and efficiency ratios
  • Capital structure and debt service ratios

Human / Animal Health Biotechnology
(see links for individual reports)

Financial benchmarking section of these reports provides an analysis of industry profit and expenses as a percentage of revenue by major category (e.g., purchases, wages, depreciation, marketing, rent, utilities, other costs, and earnings before interest and taxes) for the most recent year and line graphs indicating trends for each category over the past five years. Sample report can be viewed free online.

More Resources »
Compensation and Salary Surveys

Executive Compensation Report

Annual executive compensation study provides an in-depth look at salaries, bonuses, other short-term and long-term incentives, and total direct compensation for top-level executives (e.g., chief executive officer, chief financial officer, chief operating officer, research and development officer, business and corporate development officer, and legal officer) of publicly-traded U.S. biopharmaceutical companies.

ERI Economic Research Institute
Biotechnology and Pharmaceuticals Salary Survey

Annual salary survey provides compensation data for personnel employed by companies engaged in medical, agricultural, and industrial biotechnology activities, with compensation information provided for 12 executive and 153 non-executive salaried job positions including annual base salary, incentive and variable pay such as bonuses, commissions, and rewards, and total direct annual compensation.

More Resources »
Business Valuation Resources

Levin Associates
Biotechnology Sector - M&A Transactions Spreadsheet

Excel spreadsheet provides deal-level data for publicly-announced mergers and acquisitions in this sector over a two-year period, with information provided for these transactions including price paid, deal terms, acquisition target financial performance, and price/revenue and price/income multiples. Single-page excerpt from the spreadsheet that includes sample transaction data is available online.

Business Valuation Resources, LLC
DealStats® - Private and Public Company Transaction Data

Interactive database provides detailed transaction data for over 38,000 private and public companies sold for prices ranging from under $250,000 to over $500,000,000, with valuation measures provided including market value of invested capital as a multiple of revenue, gross profit, EBIT, EBITDA, SDE, and book value of invested capital. User guide, free webinar, and sample reports are available online.

More Resources »

Related Industries:
Ethanol and Biofuel Production
Drug Wholesalers and Distributors
Pharmaceutical Manufacturers
Testing Laboratories


About | Contact | Privacy | Terms

© 1999-2020 Valuation Resources, LLC